Telemedicine Tech Firm Garners Five New US Clients
Source: Streetwise Reports  (1/10/20)
With these contracts, the company extends its geographic footprint to an additional county. More >

Life Sciences Firm Upgrades to OTCQB Venture Market
Source: Streetwise Reports  (1/10/20)
This is a significant achievement of this developing company. More >

Developer Completes Design Verification of Imaging Device for Bladder Cancer
Source: Streetwise Reports  (1/10/20)
In doing so, it gets one step closer to market approval from U.S. regulators. More >

Ultragenyx Shares Increase 30% on Results from Phase 1/2 OTC Deficiency Study
Source: Streetwise Reports  (1/10/20)
Rare disease biopharmaceutical company Ultragenyx Pharmaceutical's shares traded 30% higher after the firm reported positive topline results from Cohorts 2 and 3 in its Phase 1/2 study of DTX301 gene therapy in Ornithine Transcarbamylase Deficiency. More >

Explorer Continues Defining 'World-Class Alkaline Gold System' in Fiji
Source: Streetwise Reports  (1/9/20)
The work the company has conducted to date at the project and the implications are discussed in a Scarsdale Equities report. More >

Explorer Reports Final Results of 2019 Channel Sampling
Source: Streetwise Reports  (1/9/20)
The program targeted a historical mine at the explorer's Nevada project. More >

Uranium-Vanadium Company Provides Updates
Source: Streetwise Reports  (1/9/20)
The firm will attend the Vancouver Resource Investment Conference 2020. More >

Drill Program to Start This Month at Athabasca Project
Source: Streetwise Reports  (1/9/20)
All permits are in hand, and the drill rig will be mobilized soon. More >

Applied Genetic Tech's Shares Double on 6-Month X-Linked RP Study Results
Source: Streetwise Reports  (1/9/20)
Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and meaningful improvements in central visual sensitivity and advised that it plans to initiate a pivotal trial by year-end 2020. More >

Developer of Oncology Therapeutics to Have 'Catalyst Rich' 2020
Source: Streetwise Reports  (1/8/20)
The near-term events expected to trigger movement of the biotech's share price are outlined in a ROTH Capital Partners report. More >

Palladium-Copper Project PEA Shows Robust Economics
Source: Streetwise Reports  (1/8/20)
The study suggests a low-cost mining operation at the Ontario property is possible. More >

Explorer Expands, Links Second Zone to First at Gold Project in Idaho
Source: Streetwise Reports  (1/8/20)
The Canadian company reports new results from its 2019 drill campaign. More >

Presence of Epithermal Gold System Confirmed at Nevada Property
Source: Streetwise Reports  (1/8/20)
The owner of the asset ascertained this from new drill results. More >

Augmented Reality Pure Play Reports Record Revenue for Month, Quarter
Source: Streetwise Reports  (1/8/20)
Q4/19 revenue is up 4,390% since the same time in the previous year. More >

Delivery Company Expands Service Agreement to Vancouver
Source: Streetwise Reports  (1/8/20)
This expansion follows the successful partnership in Calgary. More >

0

Brent Cook: Investors Should Get Boots on the Ground
Source: Maurice Jackson for Streetwise Reports  (1/8/20)
In this interview with Maurice Jackson of Proven and Probable, Exploration Insights' Brent Cook discusses the value of site visits to determining the potential of a prospect, and offers insights into various metals markets. More >

Applied Therapeutics Investors Like the ACTION in Phase 2 Galactosemia Study
Source: Streetwise Reports  (1/8/20)
Applied Therapeutics' shares traded 25% higher today after the company reported positive topline results from its Pivotal Phase 2 ACTION Study of AT-007 for use in the treatment of galactosemia. The firm expects to file for regulatory approval of AT-007 in H2/20. More >

Oil & Gas Firm Reports Positive Signs After Frack Stimulation
Source: Streetwise Reports  (1/8/20)
The energy company is now conducting fluid flowback at the Texas well. More >

World's Highest-Grade Silver Mine Targets Q4 2020 Production
Source: Bill Powers for Streetwise Reports  (1/8/20)
Bill Powers of Mining Stock Education sits down with Kevin Drover, CEO of Aurcana, to talk about the company's production plans for its high-grade project in Colorado. More >

Drone Data Firm to Acquire Leader of High-Performance FPV Drone Technology
Source: Streetwise Reports  (1/7/20)
The merger is expected to foster growth of both entities. More >

Energy Storage Systems Firm Procures Short-Term Capital
Source: Streetwise Reports  (1/7/20)
The funds are to see the company through its transition to contract manufacturing. More >

2019 Was 'A Very Good Year' for Red Lake Area Explorer
Source: Streetwise Reports  (1/7/20)
The year included achievements related to exploration and finances. More >

Jayant Bhandari: A Contrarian View of Common Western Virtues
Source: Maurice Jackson for Streetwise Reports  (1/7/20)
Maurice Jackson of Proven and Probable and Jayant Bhandari of Capitalism and Morality talk about the dangers posed by education, prosperity and democracy to economic stability and the accumulation of wealth. More >

Apellis Pharma Shares Rise 20% on Positive Top-line Data in Phase 3 PNH Trial
Source: Streetwise Reports  (1/7/20)
Shares of Apellis Pharmaceuticals opened 35% higher and established a new 52-week intraday high price today after the company announced positive top-line results from its Phase 3 head-to-head study of Pegcetacoplan (APL-2) versus Eculizumab in patients with Paroxysmal Nocturnal Hemoglobinuria. More >

Precious Metals Producers Make Progress, But Costs Are a Constant Struggle
Source: Adrian Day for Streetwise Reports  (1/7/20)
Fund manager Adrian Day reviews recent developments with precious metals producers in his portfolio. More >